Gayland O. Hethcoat II’s Insights

75 total results. Page 1 of 7.

Longevity Lens
Competing Biomarker Providers Clash: Function Health Sues Superpower Health Over Allegedly Deceptive Advertisements
News
AFS Longevity & Healthspan Industry Group and Leader Featured on Legal Strategy in Emerging Sector
Health Care Counsel Blog
CMS ACCESS Model Update: Payment Rates and Performance Targets Released for 2026–2027
Longevity Lens
ARPA-H Emerges as Top Longevity Agency Amid Funding and Staffing Fluctuations
Longevity Lens
The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies
Longevity Lens
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss
Longevity Lens
Lupo and Hethcoat Quoted on ArentFox Schiff Launch of Longevity & Healthspan Industry Group
Longevity Lens
ArentFox Schiff Launches First-of-Its-Kind Longevity & Healthspan Industry Group
Health Care Counsel Blog
Top Legal Challenges for the Health Care Industry in 2026
Longevity Lens
Staying on TEMPO: Five Things for Digital Health Companies to Know About the FDA’s New Pilot
Longevity Lens
Whoop There It Is: FDA Warning Letter Now Anchors a Class Action Against Whoop
Press Release
AFS Advises Clearwater Security and Compliance in Sale Transaction